revasca patient information page 1 - Flipbook - Page 7
REVASCA™ PATIENT INFORMATION
— References —
1. Mockl L. The emerging role of the mammalian glycocalyx in functional membrane organization and immune
system regulation. Front Cell Dev Biol. 2020;8:253.
2. Iba T, et al. Derangement of endothelial glycocalyx in sepsis. J Thormb Haemost. 2019;17:283-94.
2007;17:101-05.
4. Butler MJ, et al. The Pathological Relevance of Increased Endothelial Glycocalyx Permeability. Am. J. Pathol.
2020;190;742–751.
5. Machin DR, et al. Glycocalyx-targeted therapy ameliorates age-related arterial dysfunction. Geroscience.
2023;45(4):2351-65.
6. Machin DR, et al. Glycocalyx-targeted therapy ameliorates age-related arterial dysfunction. Geroscience.
2023;45(4):2351-65.
7. Regier M, et al. A Dietary Supplement Containing Fucoidan Preserves Endothelial Glycocalyx through
ERK/MAPK Signaling and Protects against Damage Induced by CKD Serum. Int J Mol Sci. 2022;23(24):15520.
9. Dogne S, Flamion B. Endothelial glycocalyx impairment in disease: focus on hyaluronan shedding. Am J
Pathol. 2020;190(4):768-80.
10. Wheeler-Jones CPD, et al. Targeting hyaluronan of the endothelial glycocalyx for therapeutic intervention.
Curr Opin Invetig Drugs. 2010;11(9):997-1006.
11. Vetvicka V. Evaluation of immunological activities of an organic freeze-dried inner leaf Aloe vera L. powder.
Unpublished Study.
12. Xia EQ, et al. Biological activities of polyphenols from grapes. Int. J. Mol Sci. 2010;11:622–646.
13. Allerton TD, et al. L-Citrulline supplementation: impact on cardiometabolic health. Nutrients.
2018;10(7):921.
14. Beresewicz A, et al. Ischemic preconditioning and superoxide dismutase protect against endothelial
dysfunction and endothelium glycocalyx disruption in the postischemic guinea-pig hearts. Mol Cell
Biochem. 1998;186(1-2):87-97.
2007;454(3):345-59.